Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-078195

Options or other derivatives

  • Director acquired 10,848,678 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Menzel Garry E Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +736,548 736,548 D: show line 1 in the form
Menzel Garry E Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +1,251,966 1,251,966 D: show line 2 in the form
Menzel Garry E Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +359,700 359,700 D: show line 3 in the form
Menzel Garry E Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +3,568,026 3,568,026 D: show line 4 in the form
Menzel Garry E Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +57,846 57,846 D: show line 5 in the form
Menzel Garry E Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +2,715,816 2,715,816 D: show line 6 in the form
Menzel Garry E Director 2023-07-05 Grant or award · Option to Purchase Ordinary Shares +2,158,776 2,158,776 D: show line 7 in the form
Loading xslF345X04/tm2320409-8_4seq1.xml…